Article Information
History
- September 22, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- 1Department of Pharmacology, College of Medicine, University of Jeddah, PO Box 45311, Jeddah 21512, Kingdom of Saudi Arabia; mtobaiqy{at}uj.edu.sa
- 2Independent Research Consultant, Aberdeen, UK AB32 6RU; katiemaclure{at}outlook.com
- 3Department of Family and Community Medicine, Medical Faculty, University of Tripoli, Tripoli 13275, Libya
- 4College of Pharmacy, QU Health, Qatar University, Doha, Qatar, P.O. Box 2713
- ↵*Correspondence to: Dr. Mansour Tobaiqy, Associate Professor, College of Medicine, University of Jeddah, mtobaiqy{at}uj.edu.sa
Posted September 22, 2021.
Thrombotic adverse events reported for Moderna, Pfizer and Oxford-AstraZeneca COVID-19 vaccines: comparison of occurrence and clinical outcomes in the EudraVigilance database
